These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 311413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G, Engstedt L, Franzén S, Gullbring B, Holm G, Höglund S, Killander A, Killander D, Lockner D, Mellstedt H, Palmblad J, Reizenstein P, Skarberg KO, Swedberg B, Udén AM.
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract] [Full Text] [Related]

  • 3. Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia.
    Ekert H, Colebatch JH, Matthews RN.
    Cancer; 1972 Sep; 30(3):643-7. PubMed ID: 4507080
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
    Ettinger LJ, Biener R, Finklestein JZ, Kamalakar P, Jones GR, Avramis VI, Holcenberg JS.
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C, Fujita N, Nakanishi S, Nishio A, Haruyama H, Nakagawa M, Ijichi H.
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [Abstract] [Full Text] [Related]

  • 9. Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia.
    Capizzi RL, Cheng YC.
    Med Pediatr Oncol; 1982 Nov; 10 Suppl 1():221-8. PubMed ID: 6962320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapy of acute leukemia with drug combinations which include asparaginase.
    Leventhal BG, Henderson ES.
    Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytosine arabinoside and 6-thioguanine in refractory acute lymphocytic leukemia.
    Bryan JH, Henderson ES, Leventhal BG.
    Cancer; 1974 Feb; 33(2):539-44. PubMed ID: 4521473
    [No Abstract] [Full Text] [Related]

  • 18. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA, Nesbit ME, Donaldson MH, Hittle RE, Weiner J, Karon M, Hammond D.
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [Abstract] [Full Text] [Related]

  • 19. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
    Sanz MA, Borrego D, Martín-Aragonés G, Martínez JA, Lorenzo I, Sanz G, Sayas MJ, Jarque I, Pastor E, Rafecas J.
    Sangre (Barc); 1987 Feb; 32(4):476-81. PubMed ID: 3660187
    [No Abstract] [Full Text] [Related]

  • 20. Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.
    Ansari BM, Thompson EN.
    Cancer; 1973 Aug; 32(2):294-7. PubMed ID: 4516215
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.